retatrutide a1c Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials Retatrutide Achieves Large Weight Decreases

Pinget et al., 2013

Regarding gastric emptying, injectable GLP-1RA generally produces a more pronounced and sustained delay, whereas oral semaglutide shows a modest, early-phase effect that attenuates at steady state [74]

Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, et al

Rybelsus is worthy of your consideration

Differential therapeutic effect of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound healing of diabetic ulcers and correlation to their cargoes

The need-to-know this morning Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting that the drug led to significant weight loss in a mid-stage trial